Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane

Indian Journal of Ophthalmology

Volumn 55, Issue 6, 2007, Pages 490-491

  Shanmugam, Mahesh P ^a   Mythri, H M ^a   Shetty, Nitin S ^a  

^a MANIPAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35548979460     PISSN: 03014738     EISSN: 03014738     Source Type: Journal    
DOI: 10.4103/0301-4738.36503     Document Type: Article

References (6)

1. Issa PC, Holz FG, Scholl HP. Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. Ophthalmology 2007;114:1736-42.
2. Jorge R, Costa RA, Calucri D, Scott IU. Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis. Graefes Arch Clin Exp Ophthalmol 2007;245:1045-8.
3. Charbel Issa P, Scholl HP, Helb HM, Holz FG. In: Holz FG, Spaide RF, editors. Essentials in Opthalmology. Medical Retina. Berlin, Springer; 2007. p. 183-97.
4. Postelmans L, Pasteels B, Coquelet P, El Ouardighi H, Verougstraete C, Schmidt-Erfurth U. Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young females. Am J Ophthalmol 2004;138:803.
5. Shanmugam MP, Agarwal M. RPE atrophy following photodynamic therapy in type 2A idiopathic parafoveal telangiectasis. Indian J Ophthalmol 2005;53:61-3.
6. Maia J-nior OO, Bonanomi MT, Takahashi WY, Nascimento VP, Takahashi BS. Intravitreal bevacizumab for foveal detachment in idiopathic perifoveal telangiectasia. Am J Ophthalmol 2007;144:296-9